Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 198 | 199 | 208 | 631 | 659 |
| Accounts receivable | -450 | -121 | 148 | 86 | -128 |
| Other Working Capital | -11,719 | 6,925 | 2,974 | 1,152 | 877 |
| Other Operating Activity | 5,717 | -14,157 | -7,899 | -7,000 | -8,387 |
| Operating Cash Flow | $-6,254 | $-7,154 | $-4,569 | $-5,132 | $-6,979 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -96 | -1 | -84 |
| Other Investing Activity | -45,929 | -3,954 | 7,276 | 6,782 | -12,762 |
| Investing Cash Flow | $-45,929 | $-3,954 | $7,180 | $6,781 | $-12,846 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -65 | -139 | -78 | -94 | -139 |
| Common Stock Issued | 0 | 109,740 | 26 | -71 | 179 |
| Other Financing Activity | 1,832 | 10,136 | -416 | -48 | 98 |
| Financing Cash Flow | $1,767 | $119,737 | $-469 | $-214 | $138 |
| Exchange Rate Effect | 264 | -192 | 542 | 73 | 129 |
| Beginning Cash Position | 123,021 | 14,584 | 12,318 | 10,942 | 30,234 |
| End Cash Position | 72,869 | 123,021 | 14,584 | 12,318 | 10,942 |
| Net Cash Flow | $-50,416 | $108,629 | $2,142 | $1,435 | $-19,687 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,254 | -7,154 | -4,569 | -5,132 | -6,979 |
| Capital Expenditure | N/A | N/A | -96 | -1 | -84 |
| Free Cash Flow | -6,254 | -7,154 | -4,665 | -5,133 | -7,063 |